Category: $2.3B

  • Takeda to Divest its Consumer Health Unit to Blackstone for $2.3B in Japan

    Shots: Takeda and Blackstone sign an agreement to divest it consumer health care business unit for $2.3B. The transaction expected to be closed by Mar 31, 2021 The portfolio to be divested includes OTC medicines and health products along with its lead product in the region, Alinamin. Blackstone plans to develop the business together with […]